Retraction Watch

Tracking retractions as a window into the scientific process

Search Results

Caught Our Notice: Another retraction for researcher paid $100k to leave uni

without comments

Via Wikimedia

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, just shy of 1,000 retractions were issued last year (and that doesn’t include expressions of concern and errata). So to get new notices in front of readers more quickly, we’ve started a new feature called “Caught our Notice,” where we highlight a recent notice that stood out from the others. If you have any information about what happened, feel free to contact us at retractionwatchteam@gmail.com.

Title:  Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA Pathway  and  Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway 

What caught our attention:

Read the rest of this entry »

ORI finds misconduct in case of biologist paid $100K by university to leave

with 8 comments

A biologist who studied the impact of diabetes on the eye inappropriately altered data in five images from three papers, according to a new finding of misconduct issued by the U.S. Office of Research Integrity (ORI).

Readers may be familiar with the subject of the findings: Azza El-Remessy, a former tenured associate professor at the University of Georgia (UGA) in Athens, spoke to us earlier this year about her battle with UGA. In June 2016, UGA found her guilty of research misconduct and recommended she be terminated. El-Remessy fought back, hiring a lawyer to contest the findings, and the university ultimately paid her $100,000 to leave. (For more, here’s UGA’s June 2016 investigation report and the settlement agreement between UGA and El-Remessy.) Read the rest of this entry »

Written by Victoria Stern

October 2nd, 2017 at 11:05 am

UCSF, VA investigations find “clear evidence” of misconduct in cancer papers

with 12 comments

Earlier this year, the University of California, San Francisco and the San Francisco Veterans Administration Medical Center teamed up to write a letter.

Addressed to the editorial office at the American Association of Cancer Research (AACR), the letter, parts of which have been published in a retraction notice, contained information concerning two papers on genetic risk factors for a type of kidney cancer and a type of uterine cancer, respectively, published in different AACR journals over a decade ago by researchers affiliated with the institutions.

The papers had been at the center of research misconduct investigations at both UCSF and the VA and the investigations came to the conclusion that both papers contained:

fabrication or falsification of data that constitutes Research Misconduct.

Though one of the papers has been retracted, it’s unclear what will happen to the other. [Note: See update at the bottom of the post.] Read the rest of this entry »

Why did a university pay a scientist found guilty of misconduct $100,000?

with 6 comments

Azza B. El-Remessy

Retraction Watch readers may remember a few posts about Azza El-Remessy, an eye researcher based at the University of Georgia (UGA) who had several papers retracted. One of the retraction notices explained that UGA found El-Remessy had “committed research misconduct by falsification or fabrication.”

Today, we have an update on the story in Science. As our Victoria Stern writes: Read the rest of this entry »

Written by Alison McCook

July 31st, 2017 at 1:53 pm

Eye researcher loses fourth paper for misconduct following Georgia, VA investigation

without comments

Azza B. El-Remessy

Azza B. El-Remessy

A biologist at the University of Georgia has lost a paper after an investigation revealed she had tampered with three images.

In 2014, Azza El-Remessy notched three retractions for a series of image errors. Now, a fourth retraction notice, and an expression of concern, explain there has been an investigation into her work. The investigation — conducted by two Georgia institutions, along with the Charlie Norwood Veterans Affairs Medical Center, where El-Remessy has additional appointments — has found evidence of misconduct.

The retraction notice for “Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration” explains:

Read the rest of this entry »

Molecular Vision retracts three papers from University of Georgia group with error-ridden images

with 2 comments

newmvlogoMolecular Vision has issued “full retractions” for a trio of articles by a group of eye researchers. All of the articles were led by Azza El-Remessy, director of the University of Georgia College of Pharmacy’s clinical and therapeutic graduate program.

As much as that is, there might be more still with this case.

The first paper, from 2000, was titled “Regulation of interphotoreceptor retinoid-binding protein (IRBP) gene expression by cAMP in differentiated retinoblastoma cell.” Its abstract states: Read the rest of this entry »

Written by amarcus41

September 29th, 2014 at 9:30 am